Furthermore, increased TNFα levels have been shown to be increased in diseases associated with COPD such as cardiovascular disease and as such, systemic treatment with low dose Cyclosporin A and prednisolone may result in improvements of a broad range of inflammatory conditions associated with COPD [14]. This evidence concerns the gene TNF and cardiovascular disorder.